Neuroinfectious diseases, encephalitis, and neuroinflammation represent a diverse group of conditions that significantly ...
Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...
Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better ...
Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.
LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), ...
BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ:LNTH), a $4.4 billion market cap radiopharmaceutical company, has finalized the previously announced divestiture of its single photon emission computed ...
Abstract: Simultaneous PET/SPECT imaging instruments could enable comprehensive molecular characterization by combining the very high sensitivity and spatial resolution of PET with the ability to ...
Senior Research Fellow, The Perron Institute for Neurological and Translational Science, and Research Fellow, Faculty of Health Sciences, Curtin University A recent episode of the The Kardashians ...
Cornell University and The General Hospital Corp. (Massachusetts General Hospital) have synthesized conjugates comprising a targeting moiety covalently linked to a radiolabeled metal chelator through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback